Atlas Trials

CureVac

18 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch CureVac

RecordFirmDate
Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC) (NCT07073183)CureVac2025-07-30
Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma (NCT05938387)CureVac2023-06-01
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults (NCT05252338)CureVac2022-02-07
A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19 (NCT04838847)CureVac2021-10-01
COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities (NCT04860258)CureVac2021-04-22
A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 (NCT04674189)CureVac2020-12-23
A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older (NCT04652102)CureVac2020-12-11
A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 (NCT04515147)CureVac2020-09-21
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 (NCT04449276)CureVac2020-06-18
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC (NCT03291002)CureVac2017-09-25

Track CureVac automatically

Every clearance here is in the API, with alerts when new ones post.